Novo Nordisk Pharmatech
Activities
Summary
Novo Nordisk Pharmatech is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries. By delivering excellence at every step of the supply chain, we help our customers keep products supplied to hospitals and patients. Improving lives every day.
Profile
Novo Nordisk Pharmatech was established in 1949 as FeF Chemicals, acquired by Novo Nordisk, a Danish healthcare company and world leader in diabetes care, in 1986 and has been part of the pharmaceutical group since then.
On 1 September 2015 the company’s name was changed to Novo Nordisk Pharmatech A/S. It is the leading worldwide supplier of products such as recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical and personal care industries.
Novo Nordisk Pharmatech A/S is a leading global supplier of high-quality ingredients for the biopharmaceutical and pharmaceutical industries. The company has attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy.
Cetrimide crystals from Novo Nordisk Pharmatech 1
Cetrimide crystals from Novo Nordisk Pharmatech 2
Insulin for cell culture: a short history and mechanism of actions
Scientific Research Library
Insulin increases influenza virus yield in HEK293 cells for vaccine production
Serum-free production of GAG-based virus-like particles by PEI-mediated plasmid transient transfection in mammalian suspension cells
Related Content
Jobs and People
